Prognostic impact of myosteatosis on survival with immune checkpoint inhibitors: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic impact of myosteatosis on survival with immune checkpoint inhibitors: A systematic review and meta-analysis

Published:2024-10 Issue: Volume:63 Page:829-836
ISSN:2405-4577
Container-title:Clinical Nutrition ESPEN
language:en
Short-container-title:Clinical Nutrition ESPEN

Author:

Sahin Taha Koray^ORCID,Guven Deniz Can^ORCID

Publisher

Elsevier BV

Reference46 articles.

1. Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade;Pauken;Science,2016

2. Pembrolizumab in patients with advanced triple-negative breast cancer: phase Ib KEYNOTE-012 study;Nanda;J Clin Oncol,2016

3. Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma;Schadendorf;J Clin Oncol,2015

4. Predictive biomarkers for immunotherapy efficacy in non-small-cell lung cancer: current status and future perspectives;Guven;Biomarkers Med,2020

5. Immune-checkpoint inhibitors: long-term implications of toxicity;Johnson;Nat Rev Clin Oncol,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP